STYLE="font: 10pt Times New Roman, Times, Serif">
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN PRIVATE
ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2014
Commission File Number: 001-34975
(Translation of registrant's name into English)
100-1370 Sony Place,
Winnipeg, Manitoba, Canada R3T 1N5
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
|☐ Form 20-F||☒ Form 40-F|
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
INCORPORATION BY REFERENCE
Exhibits 99.1 to this Form 6-K shall be incorporated by reference as an exhibit to the Registration Statement of IMRIS Inc. on Form F-10 (File No. 333-183820).
DOCUMENTS FILED AS PART OF THIS FORM 6-K
See the Exhibit Index hereto.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|Date: August 26, 2014||By:||/s/ Kelly McNeill|
|Title:||Executive Vice President Finance and Administration & CFO|
|99.1||News Release Dated August 26, 2014 - Highest level evidence published in Neurosurgery journal indicates better outcomes when using iMRI|
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever Imris Inc makes a similar move, sign up!
Other recent filings from the company include the following:
Imris Completes Symbis Surgical System Human Factors Study - Dec. 1, 2014